secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001822479-22-000068
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health Q3 net revenues up 10% to $249M; adjusts FY2022 guidance
----------------------------------------------------------------------

- Q3 net revenues $249M, up 10% YoY; constant currency growth 13.2%.
- Net income $25M ($0.09 diluted EPS) vs $27M ($0.10) in Q3 2021.
- Adjusted EBITDA $125M, up 7.3% YoY; Adjusted EPS $0.23, up from $0.21.
- Full-year 2022 guidance revised: net revenue growth 7-8%, Adjusted EBITDA growth 4-6%.
- Alex Dimitrief joined as General Counsel effective Nov 1, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247922000068/0001822479-22-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247922000068/shc-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001822479-22-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer